ORIC ORIC Pharmaceuticals, Inc.
$13.16
ORIC Pharmaceuticals, Inc. (ORIC) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.40 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +23.7% since its last earnings release on August 3, 2026.
ORIC Pharmaceuticals, Inc. Missed Consensus Estimates
Monday, August 3, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.40)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$13.21
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.
Sector
Healthcare
Industry
Biotechnology
Charts powered in part by Lightweight Charts™ by TradingView.